Pharma CROs draw in PE interest: 5 deals

Astorg, BayPine, Blackstone and InTandem Capital Partners are targeting the CRO sector for investments.

ByJohn R Fischer

9 May 2025•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured North America US Healthcare Top Stories